GlobalData on MSN1mon
Qnovia set to trial smoking cessation inhaler in the US
Qnovia has received clearance from the US Food and Drug Administration (FDA) to start a clinical trial for its RespiRX ...
Medscape1mon
Smoking Cessation or Reduction with Nicotine Replacement Therapy: A Placebo-controlled Double Blind Trial with Nicotine Gum and Inhaler
In conclusion, NRT (nicotine gum or inhaler) doubled the quit rate compared to placebo and was safe. Active NRT achieved sustained abstinence rates of 20.1% at 4 months and 18.7% at 12 months ...